Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer

PHASE3CompletedINTERVENTIONAL

Enrollment

1,050

Participants

Timeline

Start Date

October 31, 1998

Study Completion Date

December 31, 2004

Conditions

Ovarian CancerPrimary Peritoneal Cavity Cancer

Interventions

DRUG

carboplatin

DRUG

docetaxel

DRUG

paclitaxel

PROCEDURE

surgical procedure

Trial Locations (1)

C.R.C. Beatson Laboratories, Glasgow

All Listed Sponsors

lead

University of Glasgow

OTHER

NCT00003998 - Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer | Biotech Hunter | Biotech Hunter